Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients
This article presents current data from publications on new direction in systematic treatment of patients with psoriasis with help of "small molecules" that act intracellularly, selectively inhibiting signaling pathways responsible for production of key pro- and anti-inflammatory mediators...
Main Author: | A. L. Bakulev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2017-08-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://www.vestnikdv.ru/jour/article/view/271 |
Similar Items
-
Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients
by: A. L. Bakulev
Published: (2017-08-01) -
Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
by: O. Yu. Olisova, et al.
Published: (2019-07-01) -
The effect of apremilast therapy on skin cytokine levels in patients with psoriasis
by: Alexey A. Kubanov, et al.
Published: (2020-09-01) -
Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
by: Yu. L. Korsakova, et al.
Published: (2018-07-01) -
Using clobetasol propionate in the form of a shampoo for the treatment of patients suffering from psoriasis localized in the scalp area
by: A. L. Bakulev, et al.
Published: (2017-08-01)